Fol. Biol. 2015, 61, 91-96
https://doi.org/10.14712/fb2015061030091
Preparing Triple-Compound Heterozygous Control Material for Molecular Diagnostics of TPMT Allelic Variants
References
1. 2014) Imputation of TPMT defective alleles for the identification of patients with high-risk phenotypes. Front. Genet. 5, 1-7.
< , B., Vazquez, L., Connolly, J. J., Bradfield, J., Sleiman, P., Keating, B., Hakonarson, H. (https://doi.org/10.3389/fgene.2014.00096>
2. 1999) Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum. Mol. Genet. 8, 367-370.
< , M. M., Collie-Duguid, E. S., Powrie, R. H., Ofori-Adjei, D., McLeod, H. L. (https://doi.org/10.1093/hmg/8.2.367>
3. 2014) Preparing compound heterozygous reference material using gene synthesis technology: a model of thrombophilic mutations. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub. 158, 539-543.
< , M., Drastíková, M., Dulíček, P., Palička, V. (https://doi.org/10.5507/bp.2014.041>
4. 2014) Development of a rapid clinical TPMT genotyping assay. Clin. Biochem. 47, 126-129.
< , P. R., Abou Tayoun, A. N., Lefferts, J. A., Lewis, L. D., Tsongalis, G. J., Cervinski, M. A. (https://doi.org/10.1016/j.clinbiochem.2014.07.088>
5. 2014) Enhanced specificity of TPMT*2 genotyping using unidirectional wild-type and mutant allele-specific scorpion primers in a single tube. PLoS One 9, e91824.
< , D., Yang, Z., Xia, H., Huang, J. F., Zhang, Y., Jiang, T. N., Wang, G. Y., Chuai, Z. R., Fu, W.L., Huang. Q. (https://doi.org/10.1371/journal.pone.0091824>
6. 2007) Should TPMT genotype and activity be used to monitor 6-mercaptopurine treatment in children with acute lymphoblastic leukaemia? J. Clin. Pharm. Ther. 32, 633-639.
< , M., Andreu-Gallien, J., Mahr, A., Medard, Y., Azougagh, S., Vilmer, E., Jacqz-Aigrain, E. (https://doi.org/10.1111/j.1365-2710.2007.00858.x>
7. 2005) Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease. J. Gastroenterol. Hepatol. 20, 1149-1157.
< , R. B., Barclay, M. L. (https://doi.org/10.1111/j.1440-1746.2005.03832.x>
8. 2004) Pyrosequencing of TPMT alleles in a general Swedish population and in patients with inflammatory bowel disease. Clin. Chem. 50, 288-295.
< , S., Lindqvist, M., Almer, S., Peterson, C., Taipalensuu, J. (https://doi.org/10.1373/clinchem.2003.023846>
9. 2011) Gene synthesis: methods and applications. Methods Enzymol. 498, 277-309.
< , R. A., Miklos, A. E., Ellington, A. D. (https://doi.org/10.1016/B978-0-12-385120-8.00012-7>
10. 1999) Pharmacogenetics as a molecular basis for individualized drug therapy: the thiopurine S-methyltransferase paradigm. Pharm. Res. 16, 342-349.
< , E. Y., Evans, W. E. (https://doi.org/10.1023/A:1011909315614>
11. MacDermott, R. P. (2015) 6-mercaptopurine (6-MP) metabolite monitoring and TPMT testing in the treatment of inflammatory bowel disease with 6-MP or azathioprine. UpToDate on line [Electronic version]. Available at: http://www.uptodate.com/contents/6-mercaptopurine-6-mp-metabolite-monitoring-and-tpmt-testing-in-the-treatment-ofinflammatory-bowel-disease-with-6-mp-or-azathioprine.
12. 2010) Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease. J. Crohns Colitis 4, 623-628.
< , O., Chládek, J., Malý, J., Hroch, M., Dědek, P., Beránek, M., Krásničanová, P. (https://doi.org/10.1016/j.crohns.2010.06.005>
13. 2013) Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. Clin. Pharmacol. Ther. 93, 324-325.
< , M. V., Gardner, E. E., Sandborn, W. J., Schmiegelow, K., Pui, C. H., Yee, S. W., Stein, C. M., Carrillo, M., Evans, W. E., Hicks, J. K., Schwab, M., Klein, T. E. (https://doi.org/10.1038/clpt.2013.4>
14. 2004) A multiplexed allele-specific polymerase chain reaction assay for the detection of common thiopurine S-methyltransferase (TPMT) mutations. Clin. Chim. Acta 341, 49-53.
< , R. L., Barclay, M. L., Gearry, R. B., Kennedy, M. A. (https://doi.org/10.1016/j.cccn.2003.10.029>
15. 2012) Validation of a genotyping method for analysis of TPMT polymorphisms. Clin. Ther. 34, 878-884.
< , M., Cabaleiro, T., Ochoa, D., Novalbos, J., Chaparro, M., Gisbert, J. P., Abad-Santos, F. (https://doi.org/10.1016/j.clinthera.2012.02.017>
16. 2000) Genotyping of eight thiopurine methyltransferase mutations: threecolor multiplexing, “two-color/shared” anchor, and fluorescence- quenching hybridization probe assays based on thermodynamic nearest-neighbor probe design. Clin. Chem. 46, 1728-1737.
< , E., von Ahsen, N., Oellerich, M. (https://doi.org/10.1093/clinchem/46.11.1728>
17. 2011) APEX microarray panel for genotyping polymorphisms in cancer chemotherapy and estimation frequencies in a Slovak population. Pharmacogenomics 12, 577-592.
< , A., Minarik, G., Dzurenkova, A., Sufliarska, S., Kadasi, L., Turna, J., Mladosievicova, B. (https://doi.org/10.2217/pgs.10.199>
18. 1998a) Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population. Br. J. Pharmacol. 125, 879-887.
< , C., Debuysere, H., Mastain, B., Vinner, E., Marez, D., Lo Guidice, J. M., Chevalier, D., Brique, S., Motte, K., Colombel, J. F., Turck, D., Noel, C., Flipo, R. M., Pol, A., Lhermitte, M., Lafitte, J. J., Libersa, C., Broly, F. (https://doi.org/10.1038/sj.bjp.0702152>
19. 1998b) Detection of known and new mutations in the thiopurine S-methyltransferase gene by singlestrand conformation polymorphism analysis. Hum. Mutat. 12, 177-185.
< , C., Debuysere, H., Sabbagh, N., Marez, D., Vinner, E., Chevalier, E. D., Lo Guidice, J. M., Broly, F. (https://doi.org/10.1002/(SICI)1098-1004(1998)12:3<177::AID-HUMU5>3.0.CO;2-E>
20. 1997) Enhanced proteolysis of thiopurine S-methyltransferase (TPMT) encoded by mutant alleles in humans (TPMT*3A, TPMT*2): mechanisms for the genetic polymorphism of TPMT activity. Proc. Natl. Acad. Sci. USA 94, 6444-6449.
< , H. L., Krynetski, E. Y., Schuetz, E. G., Yanishevski, Y., Evans, W. E. (https://doi.org/10.1073/pnas.94.12.6444>
21. 1997) Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance. Ann. Intern. Med. 126, 608-614.
< , C. R., Krynetski, E. Y., Loennechen, T., Fessing, M. Y., Tai, H. L., Pui, C. H., Relling, M. V., Evans, W. E. (https://doi.org/10.7326/0003-4819-126-8-199704150-00003>
22. 2007) Clinical significance of thiopurine S-methyltransferase gene polymorphisms. Curr. Pharmacogenomics 5, 103-115.
< , S. F., Chowbay, B. (https://doi.org/10.2174/157016007780831808>